March 28th, 2011
The maker of Citalopram and Finasteride announced a voluntary recall of the two drugs Saturday due to mislabeling and possible ingestion of the wrong drug by patients.
Greenstone LLC, a subsidiary of drug giant Pfizer, announced that it is voluntarily conducting a recall, ...
January 25th, 2011

Viibryd (vilazodone hydrochloride) was approved by the U.S. Food and Drug Administration Monday to treat major depression -- also known as clinical depression -- in adults.
Viibryd is a one-of-a-kind ...
November 1st, 2010

The U.S. Food and Drug Administration has approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia.
"Schizophrenia can be a devastating illness requiring ...
October 28th, 2010

On Thursday, the U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) -- an atypical antipsychotic medication -- for the treatment of adults with schizophrenia.
Schizophrenia is characterized ...
October 7th, 2010
The U.S. Food and Drug Administration (FDA) has given the green light to the nonstimulant medication Kapvay (clonidine hydrochloride) as the first drug used to treat attention deficit hyperactivity disorder (ADHD) that can be used as an add-on therapy to stimulant medication.
Kapvay ...
August 14th, 2010
A new side effect associated with the psychiatric medication Lamictal has been discovered.
On August 12th the U.S. Food and Drug Administration (FDA) issued a new warning that Lamictal (lamotrigine) has a very low risk of causing a condition known as aseptic meningitis.
“Aseptic meningitis is ...
June 21st, 2010
After much review and public controversy, the FDA met this week and determined that flibanserin, a new medication that was hoped to be an effective treatment for female sexual arousal disorder, did not significantly improve symptoms of the disorder, and ...
December 5th, 2009

The U.S. Food and Drug Administration (FDA) handed Eli Lilly & Co. approval to market its best-selling medication Zyprexa to teens with schizophrenia or bipolar ...
December 5th, 2009

The U.S. Food and Drug Administration (FDA) last week notified health care professionals and patients about the increased risk of neural tube defects ...
December 5th, 2009

The U.S. Food and Drug Administration (FDA) announced this past week that two types of Seroquel-brand (quetiapine fumarate) atypical antipsychotic medications have been approved ...